Ulobetasol lotion - Sun Pharmaceutical Industries

Drug Profile

Ulobetasol lotion - Sun Pharmaceutical Industries

Alternative Names: Halobetasol propionate lotion- Sun Pharmaceutical Industries; HBP lotion- Sun Pharmaceutical Industries; Ultravate

Latest Information Update: 22 Aug 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Sun Pharmaceutical Industries
  • Class Anti-inflammatories; Antiallergics; Corticosteroids; Small molecules
  • Mechanism of Action Phospholipase A2 inhibitors; Steroid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Plaque psoriasis
  • Phase II Atopic dermatitis

Most Recent Events

  • 29 Jun 2017 Phase-II clinical trials in Atopic dermatitis (In children, In adults, In the elderly) in USA (Topical, Spray) (NCT03245385)
  • 16 Aug 2016 Launched for Plaque psoriasis in USA (Topical)
  • 28 Apr 2016 Chemical structure information added
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top